Renal biopsy findings in long-term cyclosporin treatment of psoriasis

British Journal of Dermatology

Volumn 136, Issue 4, 1997, Pages 531-535

  Zachariae, H ^a,b   Kragballe, K ^a   Hansen, H E ^a   Marcussen, N ^a   Olsen, S ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG SAFETY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BIOPSY; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; PSORIASIS;

EID: 0030888406     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb02136.x     Document Type: Article

References (16)

1. Griffiths C, Powles A, Leonard J et al. Clearance of psoriasis with a low dose cyclosporin. Br Med J 1986; 293: 731-2.
2. Steinsson K, Valdimarsson H. The case for cyclosporin-A in psoriatic arthritis. Inflammopharmacology 1993; 2: 131-9.
3. Powels A, Cook T, Hulme B et al. Renal function and biopsy findings after 5 years treatment with low-dose cyclosporin for psoriasis. Br J Dermatol 1993; 128: 159-65.
4. Laburthe C, Grossman R, Abi-Rached J et al. Efficiency and safety of Sandimmun for long-term treatment of chronic plaques psoriasis. Br J Vermatol 1994; 130: 366-75.
5. Menter A. Cyclosporine. Semin Dermatol 1992; 11 (Suppl. 1): 30-4.
6. Fry L. New molecules for old diseases - cyclosporin in the treatment of psoriasis. In: Skin Therapy (Marks R, Cunliffe W. eds). London: Martin Dunitz 1994: 1-7.
7. Zachariae H, Hansen HE, Kragballe K, Steen Olsen T. Morphologic renal changes during cyclosporine treatment of psoriasis. J Am Acad Dermatol 1992; 26: 415-18.
8. Altman R, Periz G, Sfakianakis G. Interaction of cyclosporine-A and non-steroidal anti-inflammatory drugs on renal function in patients with rheumatoid arthritis. Am J Med 1992; 93: 396-402.
9. Kwan J, Foxall P, Townsend J et al. Does Nifedipine ameliorate cyclosporin-A nephrotoxicity? Br Med J 1991; 295: 851.
10. Madsen J, Zachariae H, Pedersen EB. Beneficial effect of the calcium antagonist felodipine on renal hemodynamics, tubular sodium handling, and blood pressure in cyclosporine-treated dermatological patients. XIII International Congress of Nephrology. Madrid, 1995. Abstract.
11. Mihatsch N, Theil G, Ryffel B. Histopathology of cyclosporine nephrotoxicity. Transplant Proc 1988; 20 (Suppl. 3): 759-71.
12. Leaker B, Cairns H. Clinical aspects of cyclosporin nephrotoxicity. Br J Hosp Med 1994; 52: 529-34.
13. Diederich D, Skopec J, Diederich A, Fu-Xiang D. Cyclosporine produces endothelial dysfunction by increased production of superoxide. Hypertension 1991; 33: 957-61.
14. Zachariae H, Bjerring P, Heickendorff L. Plasma endothelins in psoriasis - relations to therapy. Acta Derm Venereol (Stockh) (in press).
15. Kon V, Sugiura M, Inagami T et al. Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 1990; 37: 1487-91.
16. Myers B, Netiton L. Cyclosporin-induced chronic nephropathy: an obliterave microvascular renal injury. J Am Soc Nephrol 1991; 2 (Suppl. 1): 545-52.